Camtek Ltd
CAMT- Exchange
- Nasdaq
- Industry
- Optical Instruments & Lenses
- SEC CIK
- 0001109138
In the last 90 days, Camtek Ltd insiders filed 0 open-market purchases and 7 sales; 236 institutions reported holding it in 13F filings for Q2 2026, worth $3.22B in total; superinvestors ARK Invest and Maverick Capital hold it.
- Currency
- USD
- Source
- SEC XBRL data (10-K, 10-Q, 20-F, 40-F)
- Updated
- Oct 8, 2026, 12:26 PM ET
Revenue flow, FY2025
Where the revenue went in FY2025, from the income statement below. Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue; hover over a band or a bar for the exact amount.
Income statement
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 20-F | 20-F | 20-F | 20-F | 20-F |
| Reported | – | – | – | – | – |
| Revenue | $496.1M | $429.2M | $315.4M | $320.9M | $269.7M |
| Cost of revenue | $245.8M | $219.3M | $167.7M | $161.1M | $132.3M |
| Gross profit | $250.3M | $210.0M | $147.6M | $159.9M | $137.3M |
| Operating expenses | $122.1M | $101.9M | $82.2M | $78.4M | $66.4M |
| Research and development | $48.3M | $38.3M | $31.5M | $28.9M | $23.5M |
| Selling, general and administrative | $73.8M | $63.6M | $50.8M | $49.5M | $43.0M |
| Operating income | $128.2M | $108.1M | $65.4M | $81.5M | $70.9M |
| Income tax | $1.61M | $12.7M | $9.00M | $8.24M | $11.7M |
| Net income | $50.7M | $118.5M | $78.6M | $79.9M | $60.3M |
| EPS, basic | $1.11 | $2.62 | $1.76 | $1.81 | $1.38 |
| EPS, diluted | $1.04 | $2.42 | $1.63 | $1.66 | $1.34 |
| Weighted shares, basic | 45.7K | 45.3K | 44.7K | 44.2K | 43.6K |
| Weighted shares, diluted | 50.0K | 49.4K | 48.9K | 48.2K | 45.0K |
| Margins and growth | |||||
| Gross margin | 50.5% | 48.9% | 46.8% | 49.8% | 50.9% |
| Operating margin | 25.8% | 25.2% | 20.7% | 25.4% | 26.3% |
| Net margin | 10.2% | 27.6% | 24.9% | 24.9% | 22.4% |
| Revenue growth, year over year | +15.6% | +36.1% | −1.7% | +19.0% | +73.0% |
| Net income growth, year over year | −57.2% | +50.7% | −1.6% | +32.6% | +176.8% |
Balance sheet
Each column is one fiscal year, newest first.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 20-F | 20-F | 20-F | 20-F | 20-F |
| Reported | – | – | – | – | – |
| Cash and equivalents | $177.8M | $126.2M | $120.0M | $148.2M | $241.9M |
| Short-term investments | $78.9M | $30.8M | $18.8M | – | – |
| Accounts receivable | $90.8M | $99.5M | $87.3M | $80.6M | $57.8M |
| Inventory | $112.2M | $111.2M | $85.9M | $65.5M | $58.8M |
| Total current assets | $897.0M | $620.1M | $546.8M | $557.0M | $520.2M |
| Property, plant and equipment | $65.1M | $54.2M | $42.0M | $33.1M | $25.4M |
| Goodwill | $74.3M | $74.3M | $74.3M | – | – |
| Intangible assets | $10.1M | $13.4M | $16.9M | $597.0K | $610.0K |
| Total assets | $1.26B | $892.0M | $787.7M | $677.1M | $583.8M |
| Accounts payable | $33.7M | $46.6M | $42.2M | $31.7M | $33.5M |
| Total current liabilities | $107.4M | $123.9M | $96.7M | $88.5M | $89.7M |
| Total liabilities | $642.8M | $342.8M | $311.5M | $293.0M | $290.1M |
| Shareholders' equity | $617.0M | $549.2M | $476.1M | $384.1M | $293.6M |
Cash flow statement
Each column is one fiscal year, newest first. Free cash flow is operating cash flow minus capital expenditures.
| Line item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Period end | Dec 31, 2025 | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
| Filing | 20-F | 20-F | 20-F | 20-F | 20-F |
| Reported | – | – | – | – | – |
| Operating cash flow | $141.9M | $122.2M | $79.3M | $57.8M | $61.0M |
| Capital expenditures | $14.4M | $10.1M | $8.10M | $8.20M | $4.07M |
| Free cash flow | $127.5M | $112.1M | $71.2M | $49.6M | $56.9M |
| Depreciation and amortization | $11.8M | $10.7M | $5.78M | $4.09M | $2.81M |
| Stock-based compensation | $16.9M | $14.5M | $12.6M | $10.5M | $5.82M |
| Investing cash flow | -$310.3M | -$55.9M | -$107.5M | -$150.8M | -$120.2M |
| Financing cash flow | $219.0M | -$60.0M | $182.0K | $3.00K | $194.8M |
| Net change in cash | $51.6M | $6.26M | -$28.2M | -$93.8M | $136.1M |
| Ratio | |||||
| Stock-based compensation, % of revenue | 3.4% | 3.4% | 4.0% | 3.3% | 2.2% |
Shares outstanding
Common shares outstanding as stated on the cover of each 10-K and 10-Q. The date is the cover date, not the period end; a rising count means dilution.
Notes and known gaps
How these numbers are put together, and what they can't tell you.
- Numbers come from the XBRL data in each period's original 10-K, 10-Q, 20-F or 40-F, or its amendment. They are shown as filed: later filings don't restate earlier periods here.
- Reported is the filing date of the first 8-K with Item 2.02 (results of operations) after the period ended, no later than the 10-Q or 10-K and within 120 days. Companies that release results only in the 10-Q, and foreign companies, which use Form 6-K, have none.
Known gaps
- Foreign companies that file Form 20-F or 40-F have annual statements only: their quarterly results are furnished on Form 6-K, which has no XBRL data.
- EPS and share counts are as reported at the time, not adjusted for later stock splits.
- For ADRs, EPS is per ordinary share, not per ADS (one TSMC ADS is five ordinary shares).
- For banks, revenue may be interest income only, depending on how the bank tags its filings; cost of revenue and gross profit are usually blank.
- Companies with several share classes, such as Berkshire Hathaway, may have no EPS and no cover share count.
- Depreciation and amortization is missing for some companies that report it under their own XBRL tags.